I AM A ...

I accept the Privacy Statement and I agree to comply with it. View our Privacy Statement.

This website uses cookies to better understand user behavior and provide the best experience. By continuing to use this website, you are consenting to the placement and retrieval of cookies on your computer by this website. Cookies will be stored for 90 days.

Never show this.

Press Release

February 7, 2023

Jensen Promotes Adam Dunn and Jeff Wilson

LAKE OSWEGO, Ore. — Jensen Investment Management (“Jensen”), a 100% employee-owned active equity investment management firm, today announced the promotion of Adam Dunn to Director of Trading and Jeff Wilson to Portfolio Manager, respectively.

“We congratulate Adam and Jeff on their well-deserved promotions,” said Managing Director Eric H. Schoenstein. “Over the years they have added significant value to Jensen, each bringing strong investment instincts and ultimately contributing to the firm’s mission toward quality investing. As instrumental participants in our culture and growth, we are delighted to recognize their hard work and commitment, and look forward to their future contributions towards Jensen’s continued success.”

Headshot of Jensen employee Adam Dunn

Adam Dunn

Adam joined the firm in 2015. With over 20 years of industry experience, he has both worked as an institutional equities trader and supported individual clients. Previously, he spent five plus years as a trader at StanCorp Investment Advisers and eight years as a trader with Banc of America Securities. Adam is a graduate from the University of California at Santa Cruz and holds a BA in Economics.

Headshot of Jensen employee Jeff Wilson

Jeff Wilson, CFA

Jeff joined Jensen in 2019 and has been an integral part of the Jensen Global Quality Growth Strategy, with added responsibilities for contributing to the Jensen Quality Growth Strategy. In both cases he has helped expand the investment team’s expertise to new industries and geographies. He joined Jensen from Scharf Investments. In that role, he provided equity research ideas and coverage as a generalist across both domestic and international markets in support of multiple global equity strategies. Prior to that he was a Senior Analyst and Portfolio Manager at Freestone Capital Management supporting all-cap and small-cap equity strategies. Jeff commenced his career as an equity analyst at ICM Asset Management. He earned a BA in Accounting and Business Administration with a concentration in Finance from Gonzaga University. Jeff is a CFA charterholder and a member of the CFA Society of Portland.

Related Insights

Jensen News & Insights

15 March 2023
Around the Bend: What to Tell Clients in Difficult Markets
How can advisers put the current market environment in perspective to help their clients prepare for whatever comes next?
Insights, Videos
9 March 2023
Animal Spirits Podcast: Investing in Quality Growth
Jensen Portfolio Manager Kevin Walkush joins the Animal Sprits Podcast to discuss quality growth investing, active management, return on equity, and more.
9 March 2023
Press Release: Three New Equity Ownership Shareholders
We are pleased to welcome Alexandria Sorosky, MaryAnn Dahl and Todd Schoen as the most recent additions to firm ownership.
2 March 2023
Pfizer: Short-Term Noise or Long-Term Benefits?
Pfizer stands to lose approximately $17B in sales over the next several years due to the loss of exclusivity on several large drug franchises. Find out why we believe this short-term noise may not outweigh the benefits for long-term investors.
15 February 2023
Press Release: Promotions of Adam Dunn and Jeff Wilson
We are pleased to announce the promotion of Adam Dunn to Director of Trading and Jeff Wilson to Portfolio Manager.
13 February 2023
How Diageo Is Serving Up Higher Profits with a Focus on Premium Spirits
With its marketing and distribution muscle, Diageo (DEO) can get its products in stores and bars everywhere. They also have deep pockets to buy up artisanal brands that have already built a following.
7 February 2023
Ask a Portfolio Manager: Episode 2
Portfolio Managers Eric Schoenstein and Allen Bond answer questions about the most important things FAs can tell their clients right now.
31 January 2023
With Covid Stumbles Behind It, AstraZeneca’s Superior Pipeline Can Shine
AstraZeneca can weather periodic hiccups with a diverse portfolio of blockbuster drugs, including a COVID-19 vaccine.